Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

NEW YORK CITY (WABC) -- It could be a game changer in COVID 19 testing: A company with offices in the Tri-State area received emergency authorization from the FDA for a test that could get results ...

The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

Coronavirus infections have come roaring back this year, prompting the Biden administration to renew one of its earliest responses to the COVID-19 pandemic: Free at-home test kits delivered via the ...

Before COVID-19, figuring out whether a sore throat, fever, and runny nose were caused by a cold, flu, or strep wasn’t a top priority. You either powered through, knowing you’d be miserable for a few ...

3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...

Type: COVID-19 test kits are categorized into equipment and extraction kits, rRT-PCR test kits, and reagents. Among these, rRT-PCR test kits, which enable the detection of viral RNA in respiratory ...

ZURICH, May 27 (Reuters) - Swiss drugmakers Novartis (NOVN.S), opens new tab and Molecular Partners (MOLN.S), opens new tab said on Thursday they will start clinical trials for an investigational ...